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Abstract
Background: Modic changes (MCs) have been identified as a diagnostic subgroup associated with low back pain
(LBP). The aetiology of MCs is still unknown and there is no effective treatment available. If MCs constitute a
specific subgroup of LBP, it seems reasonable to expect different effects from different treatments. The objective of
this systematic critical literature review was therefore to investigate if there is evidence in the literature that the
presence of MCs at baseline is associated with a favourable outcome depending on the treatment provided for
LBP.
Methods: The databases MEDLINE and EMBASE were searched for relevant articles from 1984 to December 2010.
A checklist including items related to the research questions and quality of the articles was used for data
extraction and quality assessment. Of the 1650 articles found, five (six studies) were included in this review but
because the studies were so heterogeneous, the results have been reported separately for each study.
Results: The treatments studied were: lumbar epidural steroid injections (n = 1), lumbar intradiscal steroid
injections (n = 2), lumbar disc replacement (n = 1), fusion surgery (n = 1) and exercise therapy (n = 1). One of the
two studies investigating treatment with intradiscal steroid injections and the study investigating fusion surgery
reported that MCs were positively associated with the outcomes of pain and disability. The other study on lumbar
intradiscal steroid injections and the study on lumbar epidural steroid injections reported mixed results, whereas
the study on lumbar disc replacement and the study on exercise therapy reported that MCs were not associated
with the outcomes of pain and disability.
Conclusions: The available studies on the topic were too few and too heterogeneous to reach a definitive
conclusion and it is therefore still unclear if MCs may be of clinical importance when guiding or prescribing the
‘right’ treatment for a patient with LBP.
Background
Low back pain (LBP) is a large problem in the Western
world. It has considerable financial consequences both
for the individual person and for society. Currently, less
than 15% of patients seeking care for LBP are thought
to have specific causes of LBP [1], leaving the remaining
85% classified as having ‘non-specific LBP’. Previous stu-
dies of various types of treatment show only little or no
treatment effects in patients with non-specific LBP [2].
One explanation for this could be that non-specific LBP
is a symptom caused by several different pathologies,
thereby dividing patients into different pathological sub-
groups. If this were the case, it would not be surprising
if the effect of treatment were often unimpressive, as
these unidentified subgroups would be treated without
any evidence-based rationale. Therefore, more knowl-
edge on different methods of subgrouping of patients in
relation to indications for various treatment approaches
would be very helpful, as it would improve the possibili-
ties for a more targeted treatment approach.
One such possible subgroup, Modic changes (MCs),
have recently been associated with LBP [3]. MCs appear
to be a stage of the disc degeneration process [4-7].
They were first defined in the literature by Modic et al.
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[8] who described two types (type I and II) of signal
changes visible on magnetic resonance imaging (MRI).
This research group also made a histological examina-
tion of the findings which revealed fissured endplates
and vascular granulation tissue adjacent to the endplate
in type I, and disruption of the endplates as well as fatty
degeneration of the adjacent bone marrow in type II.
Modic et al. also described a third type as corresponding
to sclerosis seen on radiographs [9]. Although it is
uncertain whether ‘normal’ disc degeneration is asso-
ciated with LBP, an association between MCs and LBP
was found in a systematic review by Jensen et al. who
reported a positive association in seven out of ten stu-
dies with odds ratios from 2.0 to 19.9 [10].
There are two main theories as to why MCs develop -
a biomechanical theory and an infection theory. The
first theory is that MCs are caused by mechanical stress
[11]. The degeneration of the disc leads to changes in
the mechanical conditions in and around the disc [4,12].
Improper loading and shear forces then cause micro-
fractures of the endplate resulting in inflammation in
the vertebral endplate and the adjacent bone marrow
[13,14]. Jensen et al. found that persons from the Danish
general population with disc degeneration, bulges or
herniations had twice the odds of new endplate changes
(MCs) over four years compared with persons with nor-
mal disc contours or no degeneration [15], and Albert
et al. found that among patients with disc herniation at
baseline 17% had developed new MCs type I at 14-
months follow-up at the same vertebral level as the pre-
vious herniated disc [16].
The second theory is that the inflammation and
oedema in the vertebral endplate are caused by a bacter-
ial infection in the associated disc [11]. Following a disc
herniation, new capillarisation and inflammation occur
which are thought to be a ‘port’ for anaerobic bacteria to
enter the disc. Sterling et al. [17] found the presence of
low virulent bacteria in 53% of the disc material har-
vested from surgery on herniated discs whereas Carricajo
et al. [18] found only 7%, and argued that the presence of
bacteria was due to contamination of the disc samples.
The debate about the presence of bacteria in MCs type I
is ongoing as Wedderkopp et al. [19] found no trace of
anaerobic bacteria in 24 biopsies taken from vertebrae
affected by MCs type I. However, Ohtori et al. [20] found
that 4 patients out of 71 with MCs type I at baseline
developed clinical symptoms of pyogenic spondylitis over
a two-year period, and that 3 of those patients had a pyo-
genic infection confirmed with a biopsy.
If MCs constitute a specific subgroup of LBP, one
would expect different outcomes with different treat-
ments for this condition. However, this would depend on
the etiology of this pathology, which remains conten-
tious. If the mechanical theory is correct, one would
expect alleviation of symptoms with rest, because immo-
bility might be necessary to heal any micro-fractures,
whereas vigorous weight bearing exercise might prevent
micro-fracture healing. Similarly, a good outcome might
also be expected from fusion surgery, because fusion may
neutralize the biomechanical dysfunctions in the verteb-
ral segment [21]. Perhaps for this reason, some surgeons
are of the opinion that the presence of MCs is a good
indication for fusion surgery [22]. In contrast, if the bac-
terial theory is correct, the outcome should be favourable
with antibiotic treatment [23].
In other words, the presence of MCs may have an
impact on outcome, either positively or negatively, for
various types of treatments. In order to synthesise the
evidence, we performed a systematic critical literature
review. The objective was to investigate if the presence
of MCs at baseline is associated with outcomes from
different kinds of treatments for LBP.
Methods
Search strategy
The databases MEDLINE and EMBASE were searched
using the following MeSH terms and/or as free text:
‘MRI’, ‘vertebral endplate’ and ‘lumbar spine’. See addi-
tional file 1: MEDLINE search strategy. The first author
searched the databases, assisted by a research librarian.
The search period was from 1984 to December 2010.
Our search was restricted to the period after 1984,
because MRI was not commonly used in clinical settings
before that time and consequently MCs were not diag-
nosed prior to that. In addition, reviews and reference
lists were searched for further references, and experts
were contacted for any additional references.
Inclusion criteria
Articles were considered for inclusion if they were origi-
nal articles from peer reviewed scientific journals pub-
lished in English, French, German, Spanish, Swedish,
Norwegian or Danish. The inclusion criteria were:
1. Participants
Studies of living human adults diagnosed with LBP, with
endplate changes (MCs) described at baseline and who
received a described treatment and were not diagnosed
with malignancy, tuberculosis, any type of traumatic
fractures, or systemic inflammatory disease.
2. Interventions
Any intervention or combination of interventions target-
ing LBP.
3. Outcome
Any clinical outcome, including (but not restricted to)
pain, disability and return to work.
4. Study design
Prospective studies and retrospective studies, with not
less than 50 participants at baseline, providing it were
Jensen and Leboeuf-Yde BMC Musculoskeletal Disorders 2011, 12:183
http://www.biomedcentral.com/1471-2474/12/183
Page 2 of 6
possible to extract relevant data to compare treatment
outcomes either 1) in patients with or without MCs, or
2) in patients with different types of MCs.
Definition of checklist items
Relevant articles were reviewed according to a checklist
in which the authors defined a set of criteria consisting
of descriptors, quality items and study results that were
considered essential for this review. A checklist that
included the items described below was devised, tested
and improved before being used for data extraction.
1. Descriptive items
• Study characteristics: aim, study design and
description of MCs at baseline.
• Participants and treatment characteristics: age, sex,
number of participants, drop-out rates, origin of
population, disease characteristics and type of
treatment.
• Method: type of recruitment procedure, time and
number of follow-ups and outcome measures used.
2. Quality items
• No fixed set of generally accepted quality criteria
were found that suited this type of literature review
and therefore quality criteria were chosen in consid-
eration of factors important for a systematic review of
prediction of treatment outcome. We concentrated on
the following issues: 1) the generalisability of the study
sample, and 2) the trustworthiness of both the MRI
findings of MCs and the outcome variables. A sys-
tematic evaluation was conducted regarding eight spe-
cific quality check-list items applied to each study
forming the basis for an overall interpretation of the
credibility of the study results, see Table 1. The cut-
points for credibility were arbitrarily defined as percen-
tages and divided into 3 categories: 0-50% was consid-
ered ‘Unacceptable’, 51-75% ‘Fair’ and 76-100% ‘Good’.
3. Results
• Conclusions on whether MCs were found to be
associated positively, negatively, or at all, with treat-
ment effect.
Review process
In all, 1650 references were obtained and examined by
the first author on title and abstract according to the
inclusion criteria. Articles written in French were evalu-
ated by the second author. Of the 1650 references, 96
articles were retrieved in full text as hard copy and
further screened by the first author according to the
inclusion criteria. Six studies reported in five articles
were found to meet the inclusion criteria and were inde-
pendently assessed by the two authors following the
checklist. The first author compared the pair of com-
pleted checklists for consistency for each article. In the
case of inconsistencies, consensus between the two
authors was reached through discussion. The flowchart
of the review process can be seen in Figure 1.
Results
1. Description of studies
The six studies included in the review were all outcome
studies, published in English, explicitly designed to
investigate associations or predictors of treatment effect.
All studies included both men and women, with the
reported mean age between 41 and 52 years, and all the
patients were recruited from secondary care although
the procedure for recruitment differed. One study used
advertising [24], four used consecutive patient recruit-
ment [25-27] and one did not report the procedure [28].
The treatments studied were: lumbar epidural steroid
injections [25], lumbar intradiscal steroid injections
[25,28], lumbar disc replacement [27], fusion surgery
[26] and exercise therapy [24].
2. Quality assessment
In general, the quality of the studies was unacceptable to
fair. All studies reported their drop-out rates but it was
mostly unclear how the drop-outs were accounted for
and if the patients who dropped out were different from
those remaining. A reference for the validity of outcome
measures was mostly reported, but only a few of the
studies reported on reproducibility of their MRI evalua-
tion protocol, information on the evaluator, blinding (if
relevant) and if standardised MRI protocols were used.
The quality score of each individual study is shown in
Table 2.
3. Results of the review
The outcome measures of pain and disability were
reported in all included studies. We therefore chose to
Table 1 The eight questions of the quality score
Reporting on drop-out:
1) Drop-out rate reported
2) Drop-out rate accounted for
3) Analysis made, to see if the responders looked like the non-
responders
Reporting on validity:
4) Did they attempt to assure or check validity of main outcome
measures?
Reporting on MRI evaluation:
5) Reproducibility of evaluation protocol
6) Competent evaluator
7) Standardized protocol used
8) Blinding
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use only pain and disability as outcome measures in this
review. Because the studies were so therapeutically and
methodologically heterogeneous, results are reported
separately for each article.
Lumbar epidural steroid injections
Buttermann [25] investigated the efficiency of epidural
steroid injections in patients with chronic degenerative
disc disease. We considered the quality of the data to be
unacceptable. Patients with MCs type I at baseline had a
statistically significant greater improvement in disability
at 3 and 6 months but not at 12 and 24 months com-
pared with patients without MCs or with other types of
MCs. No difference in improvement was found in back
pain at any time point. As the results were only reported
in graphs, quantification of the exact differences was not
possible.
Lumbar intradiscal steroid injection
In the same article, Buttermann [25] reports on lumbar
intradiscal steroid injections in those patients who did
not show any effect of treatment with the spinal epi-
dural steroid injections given in the first study. We con-
sidered the quality of the data to be unacceptable. The
author reports a significant difference between the
groups at baseline in disability but not in pain. There-
after, patients with MCs type I had a significantly
greater improvement at 3, 6, 12 and 24 months in dis-
ability, and at 3 and 6 months in pain, compared with
the other patients. The results are shown as graphs, so
again, quantification of the differences was not possible.
Also, Fayad et al. [28] investigated the effect of lumbar
intradiscal steroid injections in patients with chronic dis-
cogenic LBP and MCs. We considered the quality of the
data to be fair. They found that patients with MCs type I
and also those with mixed type but predominantly MCs
type I had a significantly higher reduction in pain at 1
month but not at 3 and 6 months compared with the
reduction in pain in patients with mixed types but predo-
minantly MCs type II. There was no significant difference
in disability between different types of MCs.
Lumbar disc replacement
Siepe et al. [27] tested the effect of total lumbar disc
replacement in patients with LBP and degenerative disc
disease. We considered the quality of the data to be
unacceptable. The presence of MCs did not have any
significant influence on the overall outcome compared
with patients without MCs, when measured at 3, 6, 12,
24 or 36 months.
Fusion surgery
Esposito et al. [26] tested the effect of lumbar fusion in
patients with chronic discogenic LBP in a prospective
study. We considered the quality of the data to be fair.
They found that patients with MCs type I, MCs of
mixed type I and II and those without MCs improved
significantly in pain and disability at a mean follow-up
time of 14 months. Patients with MCs type II did not
improve significantly. An analysis of the difference in
improvement between groups was not reported. As the
results are only shown in graphs, quantification of the
difference was also not possible.
Exercise therapy
In a prospective study, Kleinstück et al. [24] tested the
effect of exercise therapy in patients with chronic
Figure 1 Flowchart of review process.
Table 2 The quality of the studies according to the
quality score
First author and type of
treatment
1 2 3 4 5 6 7 8 Total
(%)
Buttermann [25]
Epidural steroid injection
+ + - + - - - - 3
(38%)
Buttermann [25]
Intradiscal steroid injection
+ + - + - - - - 3
(38%)
Fayad et al. [28]
Intradiscal steroid injection
+ + - - + + + - 5
(63%)
Siepe et al. [27]
Disc replacement
+ + - +* - - - - 2.5
(31%)
Esposito et al. [26]
Fusion surgery
+ NA NA +* - + + - 3.5
(58%)
Kleinstück et al. [24]
Exercise therapy
+ + + + + + + + 8
(100%)
The numbers from 1-8 refer to the corresponding question in Table 1. Each
question was scored positive (+) if the item was fulfilled, negative (-) if the
item was not fulfilled and (NA) if not applicable. *Only reported for one of
two outcomes and therefore counted as 0.5 in the overall score.
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nonspecific LBP. We considered the quality of the data
to be good. They found that MCs did not significantly
predict a poorer outcome in pain and disability immedi-
ately after end of treatment at 3 months or at the 12
months follow-up.
For a summary of the results, see Table 3. For details
of each study see additional file 2: Details of the six
included studies.
Discussion
The studies identified in this review were too few and
too heterogeneous to reach a definitive conclusion as to
whether MCs can be used to guide optimal treatment in
patients with LBP. In addition, only 1 of the 6 studies
was considered to be of good quality. The results of that
study, which investigated the effect of exercise, were not
particularly helpful, as they failed to differentiate MCs
into sub-categories. Obviously, this is important, if var-
ious stages of MCs require different types of treatments.
The other studies, of varying quality that never
exceeded fair, provided a confusing picture. Results var-
ied for different types of treatments, at different times of
follow-up and for different outcomes, in a manner that
could not easily be interpreted. The only treatment
investigated in two separate studies was lumbar intradis-
cal steroid injections but the results did not concur.
Furthermore, results could not be obtained from enough
studies to make a systematically reporting of the stan-
dardised effect size or another uniform measure
meaningful.
For those reasons, it was also not possible to interpret
the findings relative to the main theories on the etiology
of MCs. There was not enough weight of evidence in
favour of the biomechanical theory and we found no
studies that could directly cast any light on the bacterial
theory.
A potential weakness of this study is that it is possible
that we missed some studies on this subject, even
though the search was comprehensive and included sev-
eral languages other than English. Also, some relevant
studies may have been overlooked, as the initial screen-
ing of abstracts and titles was undertaken by only one
of the authors. Furthermore, as we were unable to find
any broadly accepted quality check-lists for this type of
study, we designed our own. The presence of other
quality criteria could have resulted in another judgment
of the quality of this study, although it is unlikely this
would have changed the interpretation of the results.
The weaknesses identified in this review make it rele-
vant to comment on the need for future studies to
respect certain methodological criteria. Two types of
study designs would be suitable. 1) The one arm pro-
spective outcome study with internal control groups i.e.
the presence/absence of MCs. 2) A better design is the
randomised controlled trial (RCT). RCTs should be con-
ducted and reported according to general recommenda-
tions [29]. In order to study the predictive value of MCs
it would be necessary to define its various types (such as
type I, type II and mixed types). Also, obviously, the
normal steps to avoid selection bias and bias in data
interpretation must be taken.
Conclusions
In conclusion, the studies in this review were too few,
too heterogeneous and often lacking in adequate metho-
dological rigour, to make a definitive conclusion as to if
and how MCs are an indication for specific therapies for
LBP. Therefore, although MCs may be associated with
pain, it remains unclear if MCs are of clinical impor-
tance for prescribing treatment for a patient with LBP
and more high quality research on the topic is needed.
It also seems necessary to differentiate the types of MCs
in any future analysis of treatment effects involving
patients with MCs.
Additional material
Additional file 1: MEDLINE search strategy. Details of the search
strategy used in the MEDLINE database.
Additional file 2: Details of the six included studies. Details on
design, number of participants, number of participants with Modic
Table 3 Association between type of MCs at baseline and
the outcome in pain and disability
Type of treatment
and subgroups
Outcome
measures
Association
at
follow-up
(months)
1 3-6 12-24
Epidural steroid injections [25] Pain (VAS) - -
MCs type I vs. type II, III and non-
MCs
Disability (ODI) + -
Intradiscal steroid injections [25] Pain (VAS) + -
MCs type I vs. type II, III and non-
MCs
Disability (ODI) + +
Intradiscal steroid injections [28] Pain (VAS) + -
MCs type I vs. type II Disability(QDS) - -
Disc replacement [27] Pain (VAS) - - -
MCs vs. non-MCs Disability (ODI) - - -
Fusion surgery [26] Pain (VAS) +
MCs type I vs. type II and non MCs Disability (JOA) +
Exercise therapy [24] Pain (VAS) - -
MCs vs. non-MCs Disability (RM) - -
The reported association between type of MCs at baseline and the outcome
in pain and disability at 1, 3-6 and 12-24 months follow-up. +: positive
association, -: no association, ODI: Oswestry disability index, QDS: Quebec
disability score, JOA: Japanese Orthopaedic Association score, RM: Roland
Morris Questionnaire, VAS: Visual Analogue Scale.
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changes at baseline, intervention procedure and drop-out rate of the six
included studies.
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